Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05491616
Title Nivolumab During Active Surveillance After Neoadjuvant Chemoradiation for Esophageal Cancer: SANO-3 Study (SANO-3)
Acronym SANO-3
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Erasmus Medical Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries NLD


No variant requirements are available.